MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with S

Sodium cromoglicate

Sodium cromoglicate 100mg capsules

Use with caution

Stability notes for Sodium cromoglicate 100mg capsules

Protect from light and store in airtight containers. Protect from moisture - hygroscopic.

Provenance

This compatibility recommendation is derived from Nalcrom 100mg capsules (Sanofi).

Suppliers (7) of Sodium cromoglicate 100mg capsules
Nalcrom 100mg capsules (Lexon (UK) Ltd)
Nalcrom 100mg capsules (Sigma Pharmaceuticals Plc)
Sodium cromoglicate 100mg capsules (A A H Pharmaceuticals Ltd)
Sodium cromoglicate 100mg capsules (Accord-UK Ltd)
Sodium cromoglicate 100mg capsules (Alliance Healthcare (Distribution) Ltd)
Sodium cromoglicate 100mg capsules (Drugsrus Ltd)
Sodium cromoglicate 100mg capsules (Somex Pharma)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.